Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

ClinicalTrials.gov ID: NCT00003834

Public ClinicalTrials.gov record NCT00003834. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 6:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of Patients With Unresectable Metastatic Adenocarcinoma of the Colon or Rectum (Per 04/99 Amendment) Old Title: A Phase II Study of Patients With Unresectable Metastatic Adenocarcinoma of the Colon or Rectum Confined to the Liver

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with liver metastases from colorectal cancer.

Study identification

NCT ID
NCT00003834
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
44 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 1999 (Type not available)
Primary completion
Dec 2005 (Actual)
Completion
Dec 2005 (Actual)
Last update posted
Jul 6, 2016

1999 – 2005

United States locations

U.S. sites
20
U.S. states
12
U.S. cities
20
Facility City State ZIP Site status
CCOP - Scottsdale Oncology Program Scottsdale Arizona 85259-5404 —
CCOP - Illinois Oncology Research Association Peoria Illinois 61602 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
CCOP - Cedar Rapids Oncology Project Cedar Rapids Iowa 52403-1206 —
CCOP - Iowa Oncology Research Association Des Moines Iowa 50309-1016 —
Siouxland Hematology-Oncology Sioux City Iowa 51101-1733 —
CCOP - Wichita Wichita Kansas 67214-3882 —
CCOP - Ochsner New Orleans Louisiana 70121 —
CCOP - Ann Arbor Regional Ann Arbor Michigan 48106 —
CCOP - Duluth Duluth Minnesota 55805 —
Mayo Clinic Cancer Center Rochester Minnesota 55905 —
CentraCare Clinic Saint Cloud Minnesota 56303 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68131 —
Medcenter One Health System Bismarck North Dakota 58501 —
CCOP - Merit Care Hospital Fargo North Dakota 58122 —
Altru Health Systems Grand Forks North Dakota 58201 —
CCOP - Toledo Community Hospital Oncology Program Toledo Ohio 43623-3456 —
CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania 17822-2001 —
CCOP - Sioux Community Cancer Consortium Sioux Falls South Dakota 57105-1080 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003834, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 6, 2016 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00003834 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →